2BB score and signals
ArriVent BioPharma, Inc.’s current 2BB score is 19 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 50 | Stable |
| Quality | 80 | Very Strong |
2BBBullish & Bearish
ArriVent BioPharma, Inc. (AVBP) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 19 out of 100.
ArriVent BioPharma, Inc.’s current 2BB score is 19 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 50 | Stable |
| Quality | 80 | Very Strong |
| Headquarters | Newtown Square, Pennsylvania, United States |
| Founded | 2021 |
| Employees | 77 |
| 52-week range | $16.10 – $35.83 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-03 | — | -1.1446 | — | $0.00 |
| 2026-11-09 | — | -1.0901 | — | $0.00 |
| 2026-08-18 | — | -1.0071 | — | $0.00 |
| 2026-05-11 | — | -0.9125 | — | $0.00 |